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Diffusion-Weighted Spectroscopy: A Novel Approach to
Determine Macromolecule Resonances in Short-Echo
Time 1H-MRS
N. Kunz,1,2 C. Cudalbu,1 V. Mlynarik,1 P. S. Hu¨ppi,2 S. V. Sizonenko,2
and R. Gruetter1,3,4*
Quantification of short-echo time proton magnetic resonance
spectroscopy results in >18 metabolite concentrations (neuro-
chemical profile). Their quantification accuracy depends on
the assessment of the contribution of macromolecule (MM)
resonances, previously experimentally achieved by exploiting
the several fold difference in T1. To minimize effects of hetero-
geneities in metabolites T1, the aim of the study was to
assess MM signal contributions by combining inversion re-
covery (IR) and diffusion-weighted proton spectroscopy at
high-magnetic field (14.1 T) and short echo time (58 msec) in
the rat brain. IR combined with diffusion weighting experi-
ments (with d/D 5 1.5/200 msec and b-value 5 11.8 msec/
mm2) showed that the metabolite nulled spectrum (inversion
time 5 740 msec) was affected by residuals attributed to cre-
atine, inositol, taurine, choline, N-acetylaspartate as well as
glutamine and glutamate. While the metabolite residuals were
significantly attenuated by 50%, the MM signals were almost
not affected (<8%). The combination of metabolite-nulled IR
spectra with diffusion weighting allows a specific characteri-
zation of MM resonances with minimal metabolite signal con-
tributions and is expected to lead to a more precise
quantification of the neurochemical profile. Magn Reson
Med 64:939–946, 2010. VC 2010 Wiley-Liss, Inc.
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INTRODUCTION
In vivo short echo time (TE) proton magnetic reso-
nance spectroscopy (1H-MRS) at high-magnetic field
benefits from increased signal-to-noise ratio (SNR) and
spectral dispersion, which improve quantification ac-
curacy and precision, resulting in the direct measure-
ment of the concentrations of about 18 metabolites
(composing the neurochemical profile) in the rodent
brain (1).
The accuracy of the quantification of the neurochemi-
cal profile is critically dependent on the estimation of
the contribution of macromolecule (MM) resonances to
the spectrum, overlapping with the metabolite’s resonan-
ces. Therefore, an accurate assessment of the MM contri-
bution is important since a biased estimation of the MM
can lead to errors in the obtained metabolite concentra-
tions (1,2). Since the MM resonances linewidth, in con-
trast to that of metabolites, does not increase substan-
tially with B0, it renders the distinction of MM signals
from those of coupled spin systems more difficult. Fur-
thermore, the absolute quantification of the MM concen-
trations may provide relevant information as a disease
marker (3,4).
Different techniques to estimate the MM signals have
been developed during the past years. When treating the
MM as a mathematical unknown, a least-square fit using
a sum of splines, wavelets, sinusoids, or polynomials
with adjustable parameters to approximate the MM sig-
nals have been used (5–11). The MM baseline has also
been assessed in a mathematical preprocessing step by
modeling of the MM signals in the frequency domain
with wavelets (1,7) or in the time-domain using singular
value decomposition (2,4) and subsequent subtraction;
truncation of initial data points (8,9); and ‘‘subtract’’ (5)
or numerical filter approach (10). However, all the meth-
ods based on such mathematical modeling provide only
an approximation of the true in vivo MM spectra (10–
12). Although such mathematical approaches may allow
a reasonably reliable estimation of the in vivo MM spec-
tra at high-magnetic fields, where the MM spectrum
includes relatively narrow resonances, additional prior
knowledge is necessary for an accurate estimation of
brain metabolite concentrations.
Therefore, to provide the necessary prior knowledge,
an experimental assessment of the MM contributions,
based on the separate acquisition of the in vivo MM
spectra using the inversion recovery (IR) method (metab-
olite-nulled spectrum) has been used (13). However,
using this experimental approach, small metabolite
residuals are still present in the metabolite-nulled spec-
tra due to variability in the T1 relaxation times of metab-
olites (1,14). The identification of these metabolite resid-
uals is mainly based on knowledge of the metabolites T1
relaxation times and the consequent removal has been
based on postprocessing techniques. Such a postpro-
cessed in vivo MM spectrum was either added to the
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basis-set (15–19) during the quantification procedure or
subtracted from the in vivo signal (11,20,21).
As described previously (1), MMs differ from metabo-
lites by their T1, which are ascribed to their larger molec-
ular size. Consequently, the MM mobility as well as their
diffusivity is more hindered. A previous study (22) has
shown than MM have an apparent diffusion coefficient
(ADC) 10–20 times lower than that of metabolites. There-
fore, the use of diffusion weighting techniques could
improve the MM baseline estimation by attenuating the
metabolites signal without altering that of MM’s.
Therefore, the aim of this study was to determine MM
resonances without any postprocessing by combining
metabolite-nulled spectra with diffusion weighting.
MATERIALS AND METHODS
Animals
In vivo experiments were performed on adult Sprague–
Dawley (Charles-Rivers, France) rats (n ¼ 5, 350 g). The
animals were anesthetized with a mixture of pure oxygen
with 1.5–2% isoflurane administrated through a nose
cone mask. Animals were restrained with a home-made
holder with ear and tooth bars. Body temperature was
measured by a rectal thermosensor and maintained at 37.5
6 1C by circulating warm water. Respiration and body
temperature were monitored during the whole experiment
by a small-animal monitor (SA Instruments, Inc., New
York, NY). Animals were sacrificed at the end of the expe-
rience. All animal experiments were conducted according
to federal and local ethical guidelines and the protocols
were approved by the local regulatory body.
Instruments and Pulse Sequences
All in vivo experiments were performed on a Varian
INOVA console (Varian, Palo Alto, CA) connected to a
14.1 T magnet with a 26-cm horizontal bore (Magnex
Scientific, Abingdon, UK), and with an actively shielded
gradient coil allowing a maximum gradient of 400 mT/m
with a fix rise time of 120 msec. A home-built quadrature
surface coil consisting of two geometrically decoupled
single loops of 14 mm of diameter was used as a
transceiver.
Fast-spin echo images (repetition time [TR]/TE ¼
6000/72 msec, echo-train length ¼ 16, field of view ¼ 23
mm  23 mm, acquisition matrix ¼ 256  256, slice
thickness ¼ 0.8 mm, six averages) were acquired in 12
min to position the voxel for spectroscopy. Localized
spectroscopy was performed on a typical volume of in-
terest (VOI) of 140 mL with a short-echo time STEAM
sequence (TE/mixing time [TM]/TR ¼ 8/200/2500) with
asymmetric radio frequency pulses for slice selection (1).
The outer volume signal was suppressed by four blocks
of slice selective pulses interleaved with the VAPOR
scheme for water signal suppression, as described previ-
ously (1). Field homogeneity was adjusted by the correc-
tion of the first- and second-order shims using the echo
planar version of FASTMAP (22).
The measurement of the in vivo MM spectrum was
performed by adding an IR and a diffusion-weighted
(DW) module to the STEAM sequence. IR was performed
using a nonselective full-passage hyperbolic secant RF
pulse (pulse length ¼ 4 msec, bandwidth ¼ 5 kHz) at dif-
ferent inversion times (TIs, ranging from 520 to 1000
msec). For the DW module, gradients were added in the
TE/2 periods and applied simultaneously along the three
gradient directions [1, 1, 1] (22) with a d/D ¼ 1.5/200
msec. The gradient strength ranged from 0 to 370 mT/m
resulting in b-values ranging from 0 to 13.19 msec/mm2.
To compensate for magnetic field drift spectra were
acquired in blocks of 16 averages, which were stored
separately and were corrected for relative shift in fre-
quency before summation.
To validate the DW-MRS protocols, the sequence was
tested into two separate phantoms filled with water with
a corrected pH of 7.4 and with respectively Cr and Glu,
or NAA, Gln and Ins dissolve at a concentration of 30
mM. To assess the phase stability during acquisition, the
spectra were acquired on a scan by scan basis for a total
of 32 spectra for each b-values. The experience was per-
formed for b-values up to 2 msec/mm2. To investigate
higher b-values, a set of in vivo data was also acquired
for b-values up to 13.9 msec/mm2. Each individual spec-
trum was analyzed by LCModel and the phase output
was used to evaluate the experiments stability.
In addition to the in vivo MM spectra, in vivo brain
spectra were acquired from five adult rats using the
ultrashort TE spin echo full intensity acquired localiza-
tion (SPECIAL) sequence (TE¼2.8 msec) (23), which pro-
vides spectra with higher SNR than STEAM. The VOI
was identical with that from where the MM spectra were
acquired. Metabolite concentrations were estimated by
LCModel. Quantification was performed using two dif-
ferent basis-sets composed of metabolite spectra simu-
lated at TE ¼ 2.8 msec, using a program written in MAT-
LAB (MathWorks, Natick, MA) based on the density
matrix formalism (24), using published values of cou-
pling constants and chemical shifts (25). The results pro-
vided the quantification of the following metabolite con-
centrations: alanine (Ala), ascorbate (Asc), aspartate
(Asp), creatine (Cr), g-aminobuttyric acid (GABA), glu-
cose (Glc), glutamate (Glu), glutamine (Gln), glutathione
(GSH), glycerophosphorylcholine (GPC), phosphorylcho-
line (PCho), myo-inositol (Ins), lactate (Lac), N-acetylas-
partate (NAA), N-acetylaspartylglutamate (NAAG),
phosphocreatine (PCr), phosphoethanolamine (PE),
scyllo-inositol (Scyllo), and taurine (Tau). To investigate
the influence of the MM signals on the quantification
results, a first basis-set contained the MM signals
acquired in vivo at 2.8 msec with IR. Residual resonan-
ces at 3.9, 3.6, 3.4, 3.2, 2.7, and 2.0 ppm were removed
by postprocessing as described previously using Hankel–
Lanczos singular value decomposition (14). The second
basis-set contained the MM signals acquired in this
study using IR combined with diffusion weighting.
RESULTS
To determine the TI where most metabolite signals were
minimized, IR measurements were performed at different
TIs. As shown in Fig. 1, the cancellation of the metabo-
lite signals occurred at different TI (e.g., Tau and NAA at
800 msec, Cr CH2 group at 600 msec and several at 740
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msec such as Glu, Gln, Ins, and more), which was
ascribed to differences in T1 (1,14). The MM signal,
which has a T1 ¼ 300–600 msec (1), was almost com-
pletely recovered at the TIs used here. Except for the
MM resonance at 0.9 ppm, which presumably comprises
signals of methyl groups with increased mobility and
correspondingly longer T1 relaxation times, the variabili-
ty of the spectral pattern in Fig. 1 can be assigned to
changing peak intensities of metabolites.
The TI showing the smallest residuals of metabolites
was 740 msec (Fig. 1). While a few narrow residuals
assigned to metabolites were still discernible at 3.9 ppm,
3.4 ppm, 3.2 ppm, and at 2.01 ppm, the identification of
incompletely nulled broader J-coupled resonances was
less apparent, due to their apparent peak width
approaching that of the MMs.
When applying IR at such determined near-optimal TI
of 740 msec, together with diffusion weighting resulted
in a progressive reduction of several spectral features in
the metabolite-nulled spectrum (Fig. 3) with b-value
increasing from 0 to 13.19 msec/mm2. For example,
resonances at 2.01, 3.2, 3.4, and 3.9 ppm are shown as
dashed line in Fig. 3. These resonances are consistent
with the presence of incompletely suppressed signals
from creatine, taurine, N-acetylaspartate, and others.
To assess the stability of the diffusion weighting
experiments, non-IR spectra were acquired with diffu-
sion weighting on a scan by scan basis to investigate
phase variation. At long diffusion time (D ¼ 200 msec)
and b-values up to 2 msec/mm2 in phantom and from
0 to 13.9 msec/mm2 in vivo, the phase stability was ac-
ceptable over the whole acquisition (cf. Fig. 2a,b). The
makeable increase in the phase instability in the phan-
tom at b-values ¼ 1.9 and 2.5 msec/mm2 was due to
strong attenuation of the metabolites resonances in solu-
tion, which made their analysis by LCModel very
uncertain.
To illustrate the negligible effect of diffusion weighting
on MM signals, the spectrum without diffusion gradients
was compared to DW spectrum (n ¼ 4) with a b-value ¼
11.8 msec/mm2. Direct subtraction of the two spectra was
possible without applying amplitude correction and
yielded a difference spectrum showing a near complete
cancellation of the MM signals (top trace in Fig. 3). Over-
all, metabolite signals were attenuated by a factor 2 in
the DW spectra, while the MM signal was affected by
<8%. The difference spectra demonstrated an increased
spectral dispersion at 14.1 T; such as the separation of
GSH, NAA, and Gln resonances at 2.5 ppm (bottom trace
in Fig. 3). The NAA resonance at 4.4 ppm is no more sat-
urated by the water suppression at 14.1 T. In addition,
the flat baseline after subtraction revealed metabolite
resonances otherwise overlapped by MM signals, e.g.,
lactate (1.32 ppm and 4.1 ppm), alanine (1.47 ppm), or
GABA (1.9 ppm) (Fig. 3).
Similar to the acquisition without IR (Fig. 3), MM sig-
nals in the IR experiments were minimally affected
(<10% at b ¼ 11.8 msec/mm2) by the diffusion weighting
(Fig. 4). Consequently, subtracting the DW spectra
acquired at b ¼ 11.8 msec/mm2 with IR (TI ¼ 750 msec)
to the one acquired at b ¼ 0 msec/mm2, showed complete
elimination of broad spectral features ascribed to MM,
such as the 0.9, 1.2, and 1.4 ppm resonances (top trace
in Fig. 4). Positive and negative signal differences were
evident in the difference spectrum (top trace in Fig. 4).
Positive residuals, consistent with a shorter T1, were
ascribed to glutamine/glutamate at 2.15 ppm, CH2 group
of N-acetylaspartate from 2.45 to 2.55 ppm, creatine at
3.9 ppm, choline at 3.2, myo-inositol at 3.55 ppm; and
the negative signals, consistent with a longer T1: CH3
group of N-acetylaspartate at 2.01 ppm, and taurine at
3.4 and 3.25 ppm.
Figure 5 shows results of quantification (black bars)
obtained using the MM spectrum acquired with IR com-
bined with DW spectroscopy (STEAM, TE ¼ 8 msec, b-
value ¼ 11.8 msec/mm2) and, in gray bars, the quantifica-
tion results obtained using the MM signal acquired with
SPECIAL at 2.8 msec using IR and corrected by postpro-
cessing. Overall, the two neurochemical profiles were in
excellent agreement, though some metabolites showed a
significant increase 30% (P < 0.05, unpaired t-test)
such as aspartate, glutamine, ascorbate, NAAG, and total
choline when using the postprocessed MM basis.
To investigate the potential influence of the increased
TE and TM on the measurement of the DW MM baseline,
three IR spectra were acquired with STEAM (TI ¼ 740
msec with (a) TE/TM ¼ 2.8/20 msec, (b) 8/20 msec, and
(c) 8/200 msec, cf. Fig. 6). From the two first traces, a
reduction of 25% of the MM signals due to T2 losses was
noted. This is in excellent agreement with apparent T2
FIG. 1. Inversion recovery spectra acquired with STEAM (TE/TM/
TR ¼ 8/200/2500 msec, 256 averages) at TI ¼ 520/610/740/850/
1000 msec. A shifted gaussian filter (exp  t  0:06ð Þ20:122 )
in combination with a light line broadening filter (exp[5t]) were
applied for modest resolution enhancement and noise reduction.
Metabolite signal intensities vary with TI (inverted signal at TI ¼
520 msec and back to positive at TI ¼ 1000 msec). The optimum
metabolite-nulled spectrum was acquired at TI ¼ 740 msec. How-
ever, contamination of N-acetylaspartate, creatine and taurine,
and others are still present.
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(19 6 0.4 msec) values published at 9.4 T (26,27). How-
ever, the use of a long TM of 200 msec shows a signifi-
cant attenuation due to T1 relaxation. As for the T2
effects, the T1 attenuation seems to show very moderate
fluctuations, resulting on an overall signal reduction
without a strong shape modification.
DISCUSSION
This study demonstrates that the MM resonances can be
identified in vivo with localized DW proton spectros-
copy. The attenuation of 50% of the metabolite signals at
b ¼ 11.8 msec/msec2 was in good agreement with ADC
values reported previously (22). Furthermore, the spec-
tral quality of the DW spectra was excellent and compa-
rable with the non-DW-spectra (Fig. 3).
To demonstrate the stability of the experiments, phan-
tom studies were performed to b-values up to 2.5 msec/
mm2 due to the higher diffusivity of metabolites in water.
Indeed, the ADC of metabolites was six times higher
than in vivo (i.e., 0.6 mm2/msec in water vs. 0.1 mm2/
msec in brain (28)). Therefore, in vivo experiments have
been performed at higher b-values (0–13.9 msec/mm2).
The stack plot presented in Fig. 2a shows modest phase
fluctuation, with a tendency to increase with the b-value.
The MM signal attenuation measured at a b-value of 11.8
mm/msec2 was very low (<8%) and corresponds to an
estimated ADC of 0.007 mm2/msec, which was in excel-
lent agreement with the previously published value (22),
suggesting a minimal influence of potential phase insta-
bilities. The additional signal loss at high b-values due
to the small phase instabilities would result in the same
reduction of all signals in a spectrum, which should not
alter the MM baseline and therefore should have a negli-
gible impact on the conclusion of this study.
In parallel to the notable spectral quality and stability
of the DW-experiments already discussed earlier, it is
important to emphasize that the notable long diffusion
time (D ¼ 200 msec) and a short-gradient duration (d ¼
1.5 msec) ensure a strong diffusion weighting (b-value
up to 13.2 mm/msec2). In addition, the TM period of
the STEAM-based sequence permitted the use of a rela-
tively short TE of 8 msec with a long diffusion time,
allowing the investigation of MM resonances (T2  30
msec) using DW-MRS. On the other side, the SPECIAL
sequence preserves the full intensity of the signal,
increasing considerably the SNR and so decreasing the
acquisition time. Therefore, for in vivo acquisition of
the neurochemical profile, the SPECIAL sequence is
more suitable. However, the design of the pulse
sequence, based on a spin-echo scheme, does not allow
sufficiently high b-value with a short TE to investigate
the MM signals. Despite the different conception of the
two sequences, SPECIAL and STEAM have quasi identi-
cal lineshape at such small TE (23). In addition, the
ultrashort TE used during this study, insure minimal
J-modulations or multiple quantum effects for both
methods (i.e., SPECIAL with TE ¼ 2.8 msec and
STEAM with TE ¼ 8 msec) (29). However, the long TM
period, in the STEAM sequence, can affect the MM sig-
nal due to probable heterogeneities in MM T1. Except
for the MM resonances at 0.9 ppm, the MM T1’s were
assumed to not be substantially different, resulting in a
global attenuation of the MM baseline without altering
the shape (cf. Fig. 6).
FIG. 2. a: Stack plot of individual in vivo 1H-MRS scans acquired with STEAM (TE/TM/TR ¼ 8/200/2500 msec and b ¼ 11.8 msec/
mm2). A line broadening filter (exp[5t]) was applied to reduce noise. No individual phase corrections were applied. Note a very stable
phase during signal averaging. b: Phase standard deviation in function of b-value measured in phantom (dark gray) and in in vivo adult
rat brain (light gray).
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The heterogeneity of the metabolite T1 relaxation times
(Fig. 1) limits the IR technique to an incomplete nulling
of the entire pool of metabolites (Fig. 4). Indeed, the
presence of the residual of the CH2 group of creatine at
3.9 ppm was already reported by Pfeuffer et al. (1) and
others (30,31) as well as that of taurine at 3.2 and 3.4
ppm. Recently, Mlyna´rik et al. (14) reported that addi-
tional residuals from metabolites contribute to the metab-
olite-nulled spectrum such as choline at 3.2 ppm, NAA
at 2 and 2.6 ppm and Ins 3.6 ppm, which have been
removed by postprocessing (32). In this study, we con-
firmed the presence of these signal residuals, and so far
uncovered additional residuals ascribed to glutamine
and glutamate at 2.1 ppm (Fig. 4).
IR at TI ¼ 740 msec led to near complete elimination
of the metabolite signals (>80%, Fig. 1), but the remain-
ing signals can still alter significantly the quantification
(e.g. creatine, taurine and N-acetylaspartate). Postpro-
cessing techniques can be used to remove the observable
residual signals and thus to estimate the true MM sig-
nals. However, at high-magnetic field (>7 T), the estima-
tion of the contaminating signals becomes increasingly
difficult as the linewidth of J-coupled metabolites
approach that of the MMs. Therefore, the lack of an
accurate and complete identification of the residuals
leads to incomplete nulling of the metabolite signals by
postprocessing. In addition, even known small contribu-
tions of broad residuals, such as Cho and Ins, are prob-
ably difficult to remove by postprocessing, due to their
large linewidth and small signal intensities.
Adding DW at a b-value ¼ 11.8 mm/msec2 to the IR
preparation attenuated 50% of the residual metabolite
FIG. 3. 1H-MRS spectra ac-
quired with STEAM (TE/TM/TR
¼ 8/200/2500 msec, 256 aver-
ages) (spectrum a) without dif-
fusion gradient (b ¼ 0 msec/
mm2) and (spectrum b) with
diffusion gradient (b ¼ 11.8
msec/mm2). A shifted gaussian




in combination with a light line
broadening filter (exp[5t])
were applied for modest reso-
lution enhancement and noise
reduction. A difference spectra
(spectrum c) was obtained af-
ter direct subtraction of peaks
(a) and (b) without any ampli-
tude correction (scaled up two
times for display). Metabolites
resonances in the lower part
of the ppm scale (g-aminobut-
tyric acid (GABA), alanine
(Ala), lactate (Lac), and aspar-
tate (Asp)), which are strongly
overlapped with macromole-
cules signals, are completely
resolved in the difference
spectra.
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signals with slight attenuation on the MM resonances
(<8%) compared with the b-value ¼ 0 metabolite nulled
spectra. Overall, it poised to a  10-fold reduction of the
metabolites signals (Fig. 4). Broader resonances overlap-
ping with those of N-acetylaspartate, choline, glutamate,
and glutamine were eliminated. It is thus likely that the
final signal obtained is composed of the MM signals
with negligible metabolite signals reduced to noise level.
The neurochemical profile assessed by LCModel using
the MM signal determined with diffusion weighting
overall agreed very well with the quantification per-
formed with MM signal corrected by postprocessing
(Fig. 5). Increasing the TE from 2 to 8 msec did not pro-
duce any relevant alteration on the MM signals (Fig. 6,
peak b), except the general 5% attenuation due to T2
FIG. 4. Diffusion-weighted spectra combined with inversion recov-
ery acquired with STEAM (TE/TM/TR ¼ 8/200/2500 msec, TI ¼
740 msec, 720 averages). Diffusion gradient were gradually
increased, giving b-value ranging from 0 (a) to 13.2 msec/mm2 (i).
The difference spectra between the b ¼ 0 (a) and b ¼ 11.8 msec/
mm2 (h) have a very flat baseline, demonstrating the insensitivity
of macromolecules to diffusion weighting experiment. Additionally,
several metabolite residuals can be identified in the difference
spectra such as creatine (Cr), inositol (Ins), taurine (Tau), N-acetyl-
aspartate (NAA), and glutamine and glutamate compounds (Glx).
FIG. 5. Neurochemical profile of five adult rats acquired with SPE-
CIAL (TE ¼ 2.8 msec) assessed with LCModel (mean 6 SD), using
the DW-MM baseline (black, STEAM, TE ¼ 8 msec) and the post-
processing MM baseline (gray, SPECIAL, TE ¼ 2.8 msec). Few
metabolites (*) show a significant increase aspartate (Asp), gluta-
mine (Gln), ascorbate (Asc), and total choline (tCho) with a P-value
<0.05 (unpaired t-test).
FIG. 6. IR-MRS with TI ¼ 740 msec acquired with the STEAM sequence. (spectrum a) MM baseline with same TE ¼ 2.8 msec and TM
¼ 20 msec than for the quantification 1H-MRS spectra. (spectrum b) The echo time was increased to TE ¼ 8 msec with TM ¼ 20 msec
to investigate T2 relaxation effects showing an overall reduction of 25%. (spectrum c) To investigate the influence of the long TM a
last MM baseline have been acquired with TE ¼ 8 msec and TM ¼ 200 msec. A significant signal dropped is visible due to T1 relaxa-
tion. No strong modulation due to T1 heterogeneities, which could alter quantification, has been noticed.
1H-NMR resonances of aspar-
tate, glutamine, ascorbate, and total choline are shown with the dashed lines.
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relaxation. However, a significant loss of signal due to T1
relaxation during the TM period of 200 msec has been
noted (cf. Fig. 6, peak c). The attenuation looks rather
homogenous, altering the absolute quantification of the
MM signals. Indeed, the shape of the MM resonances,
apart from a general scaling effect, show very little varia-
tions. Thus, the concentration increase of 30% for
some metabolites suggests incomplete metabolite nulling
in the non-DW MM spectra. Indeed, all the metabolites
showing an increase in concentration have 1H-NMR
resonances in one or both of the following frequency
ranges: 2–2.4 ppm and 3.5–4 ppm (25). Comparing these
two groups of resonances with the metabolite residuals
removed with diffusion weighting, a good agreement
with both spectral regions containing the most important
metabolite residuals can be seen (top trace in Fig. 3).
Thus, the increased concentrations of glutamine, aspar-
tate, total choline, ascorbate, and N-acetylaspartylgluta-
mate are likely due to a better elimination of these
metabolite residuals by using the diffusion weighting
technique.
The presented approach to assess the MM baseline, as
all existing techniques, remains an approximation of the
true baseline. In addition, the gap between the acquisi-
tion parameters of an optimal in vivo 1H-MRS (e.g., TE ¼
2.8 msec and TM ¼ 20 msec) and a DW-MRS sequences
(e.g., TE ¼ 8 msec, TM ¼ 200 msec, and b-value > 10
mm/msec2), may add some imperfection in the quantifi-
cation. However, the present technique improves the
state-of-art by determining the MM signals purely experi-
mentally, based on the larger molecular size of the MM
proteins compared with metabolites, which results in a
shorter T1 and a smaller ADC. Therefore, IR combined
with diffusion weighting probably leads to an accurate
identification of the MM signals obviating eliminating
the need for any postprocessing. It results in an excellent
assessment of the MM baseline with residual contamina-
tion within the magnitude of the normal measurement
variations.
We conclude that diffusion weighting combined with
IR results in a direct and accurate approach to assess
MM signals, which can be extended to any magnetic
field. The proposed technique may be limited by system
stability and subject motion, which for human systems
would be very challenging due to stronger phase varia-
tion. However, the precise identification of the metabo-
lites residuals present in the metabolite nulled spectra
may provide relevant used as prior knowledge for post-
processing techniques.
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